Cutera EBITDA Margin 2010-2023 | CUTR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cutera (CUTR) over the last 10 years. The current EBITDA margin for Cutera as of December 31, 2023 is .
| Cutera EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-09-30 |
$0.23B |
$-0.09B |
-37.83% |
| 2023-06-30 |
$0.25B |
$-0.06B |
-24.29% |
| 2023-03-31 |
$0.25B |
$-0.04B |
-16.87% |
| 2022-12-31 |
$0.25B |
$-0.03B |
-12.70% |
| 2022-09-30 |
$0.25B |
$-0.03B |
-11.95% |
| 2022-06-30 |
$0.25B |
$-0.02B |
-8.16% |
| 2022-03-31 |
$0.24B |
$-0.01B |
-3.33% |
| 2021-12-31 |
$0.23B |
$0.01B |
2.59% |
| 2021-09-30 |
$0.22B |
$0.01B |
4.17% |
| 2021-06-30 |
$0.20B |
$0.01B |
3.54% |
| 2021-03-31 |
$0.17B |
$-0.01B |
-3.64% |
| 2020-12-31 |
$0.15B |
$-0.02B |
-12.93% |
| 2020-09-30 |
$0.15B |
$-0.02B |
-14.77% |
| 2020-06-30 |
$0.16B |
$-0.02B |
-14.74% |
| 2020-03-31 |
$0.18B |
$-0.01B |
-6.74% |
| 2019-12-31 |
$0.18B |
$-0.01B |
-4.40% |
| 2019-09-30 |
$0.18B |
$-0.01B |
-6.86% |
| 2019-06-30 |
$0.17B |
$-0.01B |
-6.47% |
| 2019-03-31 |
$0.17B |
$-0.01B |
-7.88% |
| 2018-12-31 |
$0.16B |
$-0.01B |
-6.13% |
| 2018-09-30 |
$0.17B |
0 |
0.00% |
| 2018-06-30 |
$0.16B |
$0.01B |
3.68% |
| 2018-03-31 |
$0.16B |
$0.01B |
5.77% |
| 2017-12-31 |
$0.15B |
$0.01B |
7.95% |
| 2017-09-30 |
$0.14B |
$0.01B |
8.51% |
| 2017-06-30 |
$0.13B |
$0.01B |
6.02% |
| 2017-03-31 |
$0.12B |
$0.01B |
4.03% |
| 2016-12-31 |
$0.12B |
$0.00B |
3.42% |
| 2016-09-30 |
$0.11B |
$0.00B |
0.92% |
| 2016-06-30 |
$0.10B |
$-0.00B |
-1.96% |
| 2016-03-31 |
$0.10B |
$-0.00B |
-3.06% |
| 2015-12-31 |
$0.10B |
$-0.00B |
-4.21% |
| 2015-09-30 |
$0.09B |
$-0.01B |
-7.78% |
| 2015-06-30 |
$0.09B |
$-0.01B |
-9.30% |
| 2015-03-31 |
$0.08B |
$-0.01B |
-11.11% |
| 2014-12-31 |
$0.08B |
$-0.01B |
-11.54% |
| 2014-09-30 |
$0.08B |
$-0.01B |
-10.67% |
| 2014-06-30 |
$0.07B |
$-0.01B |
-10.96% |
| 2014-03-31 |
$0.08B |
$-0.01B |
-6.67% |
| 2013-12-31 |
$0.08B |
$-0.00B |
-5.33% |
| 2013-09-30 |
$0.08B |
$-0.00B |
-3.95% |
| 2013-06-30 |
$0.08B |
$-0.00B |
-2.56% |
| 2013-03-31 |
$0.08B |
$-0.00B |
-3.85% |
| 2012-12-31 |
$0.08B |
$-0.01B |
-7.69% |
| 2012-09-30 |
$0.07B |
$-0.01B |
-10.81% |
| 2012-06-30 |
$0.07B |
$-0.01B |
-12.86% |
| 2012-03-31 |
$0.07B |
$-0.01B |
-16.92% |
| 2011-12-31 |
$0.06B |
$-0.01B |
-16.39% |
| 2011-09-30 |
$0.06B |
$-0.01B |
-17.54% |
| 2011-06-30 |
$0.05B |
$-0.01B |
-20.37% |
| 2011-03-31 |
$0.05B |
$-0.01B |
-23.53% |
| 2010-12-31 |
$0.05B |
$-0.01B |
-18.87% |
| 2010-09-30 |
$0.05B |
$-0.01B |
-16.98% |
| 2010-06-30 |
$0.05B |
$-0.01B |
-13.21% |
| 2010-03-31 |
$0.05B |
$-0.01B |
-13.21% |
| 2009-12-31 |
$0.05B |
$-0.01B |
-15.09% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.051B |
$0.212B |
|
Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system.
|
